Medtech Value Framework

AdvaMed, the Medtech Association, unveiled a timer on the organization’s website to track the number of days since the Centers for Medicare and Medicaid Services (CMS) ended the coverage pathway for FDA-approved breakthrough medical devices.

Gain insights from leaders from CMS and industry experts as they delve into medtech payment policies, private payer challenges and more.

Learn the basic principles of how medical technologies are covered and paid by insurers and the challenges medtech companies face.

Medicare is the single biggest health care insurer in the United States. When Medicare covers products or services, millions of Americans benefit. 

Unfortunately, because Medicare is so big, the coverage policies are so complex, and medical technology evolves so fast, coverage often lags behind what’s available on the market. The gaps mean Medicare beneficiaries often have to wait for access to technology that would improve their health. Private insurers tend to follow Medicare’s lead, so the lag times ripple throughout the health care system.

AdvaMed, the Medtech Association, released this statement from President and CEO Scott Whitaker following the House Energy & Commerce Committee’s Subcommittee on Health markup of H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.

Today, following a legislative hearing on improving seniors’ access to innovative medical devices and technologies, AdvaMed President and CEO Scott Whitaker commended the House Energy and Commerce Committee’s Subcommittee on Health for hosting the panel. 

AdvaMed, the Medtech Association, and CapView Strategies released a white paper detailing ways to help advance the ethical incorporation of innovative artificial intelligence (AI) and software solutions into Medicare coverage and payment policies.

AdvaMed, the Medtech Association, submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the Transitional Coverage for Emerging Technologies (TCET) notice.